How Much GLP-1 To Take: A Physician’s Step-By-Step Guide

July 13, 2026

Written by: Dr. Akash Chandawarkar, Board Certified Plastic Surgeon, Mirror Plastic Surgery | Last updated: September 9, 2026

Key Takeaways

GLP-1 dosing is highly individualized and follows four phases: starting, titrating, maintaining, and troubleshooting.
Every FDA-approved GLP-1 medication begins at a low, sub-therapeutic dose so the body can adapt and side effects stay manageable.
Strict adherence to the titration schedule is essential. Rushing increases nausea and GI distress without improving weight-loss results.
Maintenance dosing is typically long-term. Stopping therapy often leads to significant weight regain within a year.
For safe, personalized GLP-1 protocols under direct physician supervision, schedule a consultation.

Meet Your Guide: Dr. Akash Chandawarkar

Dr. Akash Chandawarkar, MD, is the founder of Mirror Plastic Surgery in St. Petersburg, Florida, and the lead physician overseeing all peptide and GLP-1 therapy protocols at the practice. He graduated with Honors from Harvard Medical School through the Harvard-MIT Division of Health Sciences and Technology and completed a seven-year integrated plastic and reconstructive surgery residency at Johns Hopkins University. He also completed the Stanford University Biodesign Innovation Fellowship, training that sharpened his commitment to evidence-based, forward-looking patient care. Every GLP-1 protocol at Mirror Plastic Surgery is designed around each patient’s labs and physiology and is medically supervised throughout.

*Dr. Akash, Board-Certified Plastic Surgeon*

Book an appointment to receive a personalized GLP-1 consultation with Dr. Akash.

Step 1: Why GLP-1 Doses Vary From Person To Person

GLP-1 receptor agonists mimic glucagon-like peptide-1, a hormone that regulates appetite, gastric emptying, and blood sugar. Each medication has a different molecular structure, potency, and FDA-approved indication, so doses are not interchangeable across drugs or even across brands of the same molecule.

Key factors that influence how much GLP-1 to take include:

The specific medication prescribed (semaglutide, tirzepatide, or liraglutide)
The condition being treated (weight management versus type 2 diabetes)
Kidney function and other relevant lab values
Individual tolerance and response over time

This guide covers the three FDA-approved GLP-1 classes used for weight management: semaglutide, tirzepatide, and liraglutide. It also explains the risks associated with compounded versions.

Step 2: Know Your Starting Dose By Medication

Every FDA-approved GLP-1 begins at a low, sub-therapeutic dose. The starting dose is designed to prevent misery by allowing the gastrointestinal system to adapt before therapeutic levels are reached.

Medication	Brand Name(s)	Starting Dose	Purpose of Starting Dose
Semaglutide	Wegovy (weight loss)	0.25 mg once weekly	Acclimate body to medication
Semaglutide	Ozempic (type 2 diabetes)	0.25 mg once weekly	Acclimate body, support glycemic control
Tirzepatide	Zepbound (weight loss)	2.5 mg once weekly	Acclimate body to medication
Tirzepatide	Mounjaro (type 2 diabetes)	2.5 mg once weekly	Acclimate body, support glycemic control
Liraglutide	Saxenda (weight loss)	0.6 mg once daily	Acclimate body to medication

What To Expect In Your First Weeks

Most patients notice reduced hunger and earlier fullness within 24 to 72 hours of the first dose.¹ Mild nausea, fatigue, or reflux may occur. These typically resolve within days. Weight loss during the first month is modest, usually 2 to 4 pounds, and this is normal at the initiation dose.¹

Step 3: Follow Your Titration Schedule

Titration is built into every FDA-approved GLP-1 label and is mandatory. GLP-1s slow gastric emptying and modify satiety signaling, and the body needs time to adapt to each new exposure level before the next increase. Escalating faster than the schedule increases nausea and GI distress without improving weight loss.¹

Semaglutide (Wegovy) Titration Schedule

Tirzepatide (Zepbound) Titration Schedule

Liraglutide (Saxenda) Titration Schedule

Each dose step is held for at least four weeks. If side effects are troublesome, a provider may hold the dose longer or step back down. Never rush the schedule.

Step 4: Reach And Manage Your Maintenance Dose

The maintenance dose is the dose you stay on long term, balancing effectiveness with tolerability. Most experts recommend using the lowest effective dose, meaning the lowest amount that helps maintain weight and health goals. Many patients reach a clinically satisfactory plateau at 7.5 mg or 10 mg of tirzepatide, or at 1.7 mg of semaglutide, and do not escalate further.¹

GLP-1 therapy for weight management is typically long term. A 2025 joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society indicates that people may regain up to two-thirds of the weight lost within a year after stopping GLP-1 medications.¹ The STEP 4 trial confirmed that participants who continued semaglutide maintained their weight loss, while those switched to placebo regained nearly 7% of body weight.¹

When To Consider Adjusting Your Dose

A weight plateau, which is natural and often resolves without a dose change
Persistent side effects interfering with daily life
Cost or insurance changes
Any dose adjustment, always discussed with your physician first

Step 5: Troubleshoot Common Dosing Challenges

What To Do If You Miss A Dose

Missed-dose instructions differ by medication:

Semaglutide (Wegovy/Ozempic): If the next scheduled dose is more than 48 hours away, take the missed dose as soon as remembered. If within 48 hours, skip it and resume the regular schedule. Never take two doses within 48 hours.
Tirzepatide (Zepbound/Mounjaro): If the missed dose was less than 4 days ago, take it as soon as possible. If 4 or more days have passed, skip it and resume on the next scheduled day. Never take two doses in the same week.
Liraglutide (Saxenda): Take the missed dose within 12 hours. Otherwise skip it and resume the next day.
If more than 2 consecutive doses have been missed, contact your provider. You may need to restart at a lower dose.

How To Handle Severe Side Effects

Common side effects such as nausea, diarrhea, constipation, and vomiting are dose-dependent and typically improve within 4 to 8 weeks as the body adapts.¹ Helpful strategies include eating smaller meals, avoiding high-fat or fried foods, staying hydrated, and taking injections in the evening so peak nausea occurs during sleep.

Red flags requiring immediate medical attention include:

Severe persistent abdominal pain radiating to the back (possible pancreatitis)
Vomiting lasting over 24 hours
Signs of dehydration
Yellowing of skin or eyes

Your provider may delay the next dose increase, step you back down, or prescribe anti-nausea medication. Forcing through significant side effects is the most common path to quitting GLP-1 therapy prematurely. Another common reason patients quit or encounter danger is turning to compounded versions sold online, which leads into a critical safety warning.

The Compounded GLP-1 Warning: Why Dosing Accuracy Matters

Compounded GLP-1s, custom-made versions sold online or through unregulated channels, have grown in popularity but carry serious risks. The FDA has issued warnings about dosing errors with compounded semaglutide and tirzepatide, including reports requiring hospitalization, doses outside approved labeling, and unverified salt forms that are different active ingredients from the semaglutide in approved products.

On March 3, 2026, the FDA sent warning letters to 30 telehealth companies over false or misleading claims about compounded GLP-1s, including promotions that made compounded products sound like generic versions of approved drugs. Compounded products are not FDA-approved and may have potency, purity, or concentration issues that make accurate dosing impossible to guarantee.

Receiving GLP-1 therapy from a licensed physician who sources from reputable pharmacies, conducts lab testing, and provides ongoing personalized supervision is the standard that protects patients from these risks. Book an appointment to learn how Mirror Plastic Surgery’s medically supervised approach differs from unregulated online sources.

Why Medical Supervision Matters For GLP-1 Therapy

GLP-1 medications are powerful agents that require proper dosing, monitoring, and side-effect management. A physician can assess appropriateness, order necessary lab tests, including kidney function, blood sugar, thyroid, and hormone panels, and adjust doses based on individual response. The FDA continues to warn about counterfeit GLP-1 products that may contain the wrong ingredient, too much drug, too little drug, or none at all.

Mirror Plastic Surgery’s concierge model includes a comprehensive consultation with Dr. Akash, personalized protocols built around each patient’s labs and physiology, and direct 24/7 access to the care team via text or telemedicine. This level of oversight makes GLP-1 therapy both safer and more effective.

Your GLP-1 Dosing Checklist

Always consult a physician before starting a GLP-1 medication
Know your specific medication and its FDA-approved starting dose
Follow your titration schedule exactly as prescribed and never rush it
Report any side effects to your provider promptly
Never purchase GLP-1s from unregulated online sources
Ask your provider about compounded versions and their documented risks
Understand that maintenance is often long term and stopping frequently leads to weight regain

Beyond GLP-1: A Broader Approach To Metabolic Health

GLP-1 therapy is one tool within a comprehensive weight-management framework that also includes diet, exercise, sleep, and other peptide therapies. Mirror Plastic Surgery offers a range of peptide protocols for inflammation, anti-aging, recovery, and wellness. GLP-1s are one component of this larger, personalized toolkit.

For patients who experience gastrointestinal side effects on standard GLP-1s, the practice also offers GLP-3R, a newer-generation peptide reported to have fewer GI effects while supporting insulin resistance, weight management, and cardiovascular risk factors.

Conclusion: Your Dose Is Personal, Get Expert Guidance

GLP-1 dosing varies by medication, condition, and individual factors. Titration is essential and built into every FDA-approved label. Compounded versions carry documented safety risks. Medical supervision is the foundation of safe, effective therapy. This guide is educational, and readers should consult a qualified physician for personalized advice tailored to their health profile.

For expert guidance on GLP-1 therapy and other peptide treatments, contact Mirror Plastic Surgery in St. Petersburg, FL. Book an appointment today to schedule a consultation with Dr. Akash Chandawarkar.

Medical Disclaimer

This article is for educational purposes only and does not replace professional medical advice. Always consult a licensed healthcare provider before starting any medication.

Frequently Asked Questions About GLP-1 Dosing

Is 2 Mg Of Semaglutide A High Dose?

Two milligrams is a high dose used for type 2 diabetes management under the Ozempic label, which tops out at 2 mg. The Wegovy label for weight loss reaches a maximum maintenance dose of 2.4 mg weekly, with a recently approved higher-dose formulation available for patients who tolerate the standard maintenance dose. Any dose at or near these levels should only be taken under direct medical supervision, with regular monitoring of labs and clinical response. Patients who cannot tolerate 2.4 mg may maintain effectively at 1.7 mg, which is also a labeled option.

How Long Should I Take GLP-1 For Weight Loss?

GLP-1 therapy for weight management is typically long term and often extends to years or longer. As noted earlier, stopping GLP-1 therapy often leads to significant weight regain within a year. Major expert bodies including the American Diabetes Association, the World Health Organization, and the joint TOS/OMA/OAC guidance frame obesity as a chronic condition requiring ongoing management rather than a fixed treatment course. Duration decisions should be made in partnership with your prescribing physician, with periodic reviews of weight trend, lab values, side effects, and overall health goals.

Can I Skip A Week Of Semaglutide For Vacation?

Skipping a single dose occasionally is manageable if you follow the missed-dose instructions for your specific medication. For semaglutide, if the next scheduled dose is more than 48 hours away, take the missed dose as soon as possible. If within 48 hours, skip it entirely. If you anticipate missing more than two consecutive doses, such as during an extended trip without access to your medication, contact your provider in advance. A gap of more than two weeks may require restarting at a lower dose to avoid a return of gastrointestinal side effects, since tolerance to the drug fades during extended breaks.

What Should I Avoid While Taking Semaglutide?

Alcohol can worsen nausea and may increase pancreatitis risk in susceptible patients, so moderation or avoidance is advisable, particularly during dose escalation. High-fat, fried, and very sweet foods tend to amplify gastrointestinal side effects and are best minimized. Semaglutide slows gastric emptying, which can affect how some oral medications are absorbed, so always review your full medication list with your physician before starting. Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should avoid semaglutide, per the FDA boxed warning. Before any elective surgery or procedure requiring anesthesia, inform your care team that you are on a GLP-1 medication, because slowed gastric emptying can affect aspiration risk.

What Is The Difference Between Semaglutide And Tirzepatide Dosing?

Semaglutide (Wegovy) and tirzepatide (Zepbound) have different molecular mechanisms and potency profiles, so their doses are not directly comparable. Semaglutide activates only the GLP-1 receptor, while tirzepatide activates both the GLP-1 and GIP receptors, which contributes to its different dose range and weight-loss profile. Semaglutide for weight loss starts at 0.25 mg weekly and reaches a maintenance dose of 2.4 mg weekly over approximately 16 weeks. Tirzepatide starts at 2.5 mg weekly and reaches a maximum maintenance dose of 15 mg weekly over approximately 20 weeks. In clinical trials, tirzepatide at its highest dose produced mean weight loss of approximately 20 to 22% of body weight, while semaglutide at 2.4 mg produced approximately 15%.¹ Individual results vary significantly, and not every patient needs or tolerates the maximum dose of either medication.¹

¹ Results may vary from person to person. Editorial content, before and after images, and patient testimonials do not constitute a guarantee of specific results.

Peptide therapy is intended for wellness and optimization purposes and is not prescribed to diagnose, treat, cure, or prevent disease unless specifically stated. Many peptides are not FDA-approved and may be used off-label. Some have limited long-term safety data, with a potential for unknown risks, complications, or desensitization with prolonged use.